Stay updated with breaking news from External Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Company to present important new data from the Phase 2 SOLSTICE chronic hepatitis delta trial - - Conference call scheduled for June 5, 2024, at 6:00 a.m. ET 12:00 p.m. CEST - Vir Biotechnology
TORONTO, May 21, 2024 -- Mattr Corp. announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held virtually on May 15, 2024. A total of...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the EASL Congress has changed the Company's Phase 2 SOLSTICE hepatitis delta presentation from a late-breaker poster to an oral presentation. The
SambaNova Systems, makers of the fastest models and most efficient chips, embedded within a full-stack AI platform, announces the appointment of Lip-Bu Tan, a semiconductor visionary, as its new Executive
Investegate announcements from Preliminary Results